Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 2.645
Filtrer
1.
Wound Manag Prev ; 70(2)2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38959349

RÉSUMÉ

PURPOSE: This study aimed to assess nursing students' knowledge levels and attitudes towards the etiology, risk factors, and preventive measures of incontinence-associated dermatitis (IAD) using an escape room game. DESIGN: A mixed-method study. SUBJECTS AND SETTING: The sample size of the study was 32 students. METHODS: Quantitative data obtained with the Knowledge, Attitude and Practice of Nurses in Managing Incontinence-Associated Dermatitis Questionnaire (KAP-IAD-Q) and qualitative data obtained through FGDs following the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist were analyzed using a thematic approach. RESULTS: The average age of the participants was 22.63 ± 0.90, 87.5% of them were female (n=28), and 50% were third (n=16) and fourth-year students (n=16). KAP-IAD-Q total posttest score (88.06+7.00) was found to be high. Data obtained from the FGDs were categorized under 3 main themes: main focus areas during participation in the IAD-themed escape room game; advantages and disadvantages of teamwork in IAD management; and the game's contribution to a better understanding and classification of IAD. CONCLUSIONS: The use of the escape room game facilitated high, fast, and efficient learning of IAD knowledge and attitudes. It revealed challenges in collaborative decision-making, accurate diagnosis, distinguishing from other wounds, and attitude development in the management of IAD.


Sujet(s)
Connaissances, attitudes et pratiques en santé , Élève infirmier , Incontinence urinaire , Humains , Élève infirmier/psychologie , Élève infirmier/statistiques et données numériques , Femelle , Mâle , Enquêtes et questionnaires , Incontinence urinaire/complications , Incontinence urinaire/soins infirmiers , Incontinence urinaire/psychologie , Recherche qualitative , Dermatite/étiologie , Dermatite/psychologie , Incontinence anale/complications , Incontinence anale/psychologie , Incontinence anale/soins infirmiers , Formation au diplôme infirmier (USA)/méthodes , Jeune adulte , Compétence clinique/statistiques et données numériques , Compétence clinique/normes
3.
Int Wound J ; 21(6): e14936, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38899615

RÉSUMÉ

The study aimed to evaluate the effect of an intervention on the prevalence and severity of incontinence-associated dermatitis (IAD) in six hospitals in one state in Australia. This quasi-experimental pre-and post-study, conducted in 18 wards, was part of a larger implementation science study on incontinence-associated dermatitis. Skin and incontinence assessments were conducted on patients during February and March 2020 (pre-intervention) and July and August 2021 (post-intervention). The intervention comprised continence assessment and management, an education brochure for patients, family and caregivers on IAD, the Ghent Global IAD Categorisation Tool (GLOBIAD) and a skin care regime with patient skin protection measures (three-in-one barrier cream cloths, minimisation of bed protection layers, use of appropriate continence aid). A total of 1897 patients were assessed (pre-intervention = 964, post-intervention = 933). A total of 343 (35.6%) pre-intervention patients and 351 (37.6%) post-intervention patients had incontinence. The prevalence of hospital-acquired IAD was 6.71% in the pre-intervention group and 4.27% in the post-intervention group; a reduction of 36.3% (p = 0.159) despite higher patient acuity, prevalence of double incontinence and the COVID-19 pandemic in the post-intervention group compared with the pre-intervention group. Our multisite best practice IAD prevention and treatment intervention was able to reduce the prevalence and severity of hospital-acquired IAD, suggesting enduring effectiveness of the intervention.


Sujet(s)
Dermatite , Incontinence anale , Incontinence urinaire , Humains , Femelle , Mâle , Incontinence urinaire/complications , Incontinence urinaire/épidémiologie , Prévalence , Sujet âgé , Incontinence anale/complications , Sujet âgé de 80 ans ou plus , Dermatite/étiologie , Dermatite/prévention et contrôle , Dermatite/épidémiologie , Australie/épidémiologie , Adulte d'âge moyen , Hygiène de la peau/méthodes , , Bouquets de soins des patients/méthodes
4.
Int J Mol Sci ; 25(11)2024 May 27.
Article de Anglais | MEDLINE | ID: mdl-38891997

RÉSUMÉ

Inflammatory skin diseases highlight inflammation as a central driver of skin pathologies, involving a multiplicity of mediators and cell types, including immune and non-immune cells. Adenosine, a ubiquitous endogenous immune modulator, generated from adenosine triphosphate (ATP), acts via four G protein-coupled receptors (A1, A2A, A2B, and A3). Given the widespread expression of those receptors and their regulatory effects on multiple immune signaling pathways, targeting adenosine receptors emerges as a compelling strategy for anti-inflammatory intervention. Animal models of psoriasis, contact hypersensitivity (CHS), and other dermatitis have elucidated the involvement of adenosine receptors in the pathogenesis of these conditions. Targeting adenosine receptors is effective in attenuating inflammation and remodeling the epidermal structure, potentially showing synergistic effects with fewer adverse effects when combined with conventional therapies. What is noteworthy are the promising outcomes observed with A2A agonists in animal models and ongoing clinical trials investigating A3 agonists, underscoring a potential therapeutic approach for the management of inflammatory skin disorders.


Sujet(s)
Adénosine , Récepteurs purinergiques P1 , Humains , Animaux , Adénosine/métabolisme , Récepteurs purinergiques P1/métabolisme , Maladies de la peau/traitement médicamenteux , Maladies de la peau/métabolisme , Dermatite/métabolisme , Dermatite/traitement médicamenteux , Dermatite/anatomopathologie , Dermatite/étiologie , Inflammation/métabolisme , Inflammation/traitement médicamenteux , Inflammation/anatomopathologie , Psoriasis/traitement médicamenteux , Psoriasis/métabolisme , Transduction du signal , Anti-inflammatoires/usage thérapeutique
6.
Br J Community Nurs ; 29(6): 294-295, 2024 Jun 02.
Article de Anglais | MEDLINE | ID: mdl-38814833

RÉSUMÉ

Incontinence-associated dermatitis (IAD) is often treated a hygienic challenge, rather than a serious condition with potentially life-threatening consequences. More appropriate education on the management strategies specific to IAD is required, in order for personalised and effective care that reflects the critical nature of this condition to be provided. Francesca Ramadan provides an overview of the key elements of best practice in IAD management and treatment.


Sujet(s)
Dermatite , Incontinence anale , Incontinence urinaire , Humains , Incontinence urinaire/complications , Incontinence anale/complications , Incontinence anale/soins infirmiers , Dermatite/étiologie , Dermatite/soins infirmiers , Hygiène de la peau/soins infirmiers , Soins infirmiers communautaires , Femelle
7.
Br J Nurs ; 33(9): S16-S28, 2024 May 09.
Article de Anglais | MEDLINE | ID: mdl-38722011

RÉSUMÉ

Incontinence-associated dermatitis (IAD) is a skin inflammation caused by contact with urine or faeces or both. It has a negative effect on the patient's quality of life and is indicative of the care provided. However, globally there is a lack of empirical data on the prevalence of IAD. AIM: To identify, for the first time, the proportion of older adults in extended care settings in Ireland affected by IAD. DESIGN: Cross-sectional, multisite, point prevalence survey, across three community extended care settings for older people in Ireland. METHODS: Two clinical nurse specialists, using the Scottish Excoriation and Moisture Related Skin Damage Tool, identified the presence of IAD through clinical observation and visual skin inspection. IAD prevalence was calculated for the total population and incontinent population sets using percentages and confidence intervals (CI). RESULTS: The prevalence of incontinence was 86.4% (n=165), a significantly higher proportion were female (P=0.003). The point prevalence of IAD across the total population and incontinent population was 11.5% (22/191; 95% CI, 7.4-19.9%) and 13.3% (22/164; 95% CI, 8.5-19.5%), respectively. Being incontinent was associated with being female, more dependent (Barthel), having possible cognitive impairment, poorer mobility (Braden and Waterlow) and a high risk of pressure ulcers (Waterlow). A logistic regression analysis found no predictor variables for IAD among the variables that met the cut-off point for this analysis. CONCLUSIONS: The study provides the first point prevalence empirical data on the occurrence of IAD in Ireland. It can inform decision-making on future planning and budgeting of new quality improvement projects and act as a benchmark for ongoing auditing of IAD.


Sujet(s)
Incontinence anale , Incontinence urinaire , Humains , Femelle , Études transversales , Mâle , Irlande/épidémiologie , Prévalence , Sujet âgé , Incontinence urinaire/épidémiologie , Incontinence urinaire/complications , Incontinence anale/épidémiologie , Incontinence anale/complications , Sujet âgé de 80 ans ou plus , Dermatite/épidémiologie , Dermatite/étiologie
8.
Front Immunol ; 15: 1398453, 2024.
Article de Anglais | MEDLINE | ID: mdl-38745660

RÉSUMÉ

Idiopathic Inflammatory Myopathies are rare conditions with several heterogeneous disease subtypes. They can range from limited muscle or skin involvement to severe, systemic, life-threatening disease. Although the etiology is unknown, some evidence suggests a role for external agents, particularly drugs. Herein, we present a case of a 71-year-old woman with chronic myeloid leukemia who developed imatinib-induced dermatomyositis sine dermatitis. The presentation was predominantly muscular, characterized by proximal muscle weakness and myalgia of the lower limbs, with positive anti-Mi2a antibodies. Spontaneous recovery was observed after drug discontinuation, without the need for immunosuppressive therapy. This is the first confirmed description of an imatinib-induced dermatomyositis sine dermatitis. It reflects the importance of a high awareness from rheumatologists and hematologists to accurately anticipate and identify similar situations.


Sujet(s)
Dermatomyosite , Mésilate d'imatinib , Humains , Femelle , Sujet âgé , Dermatomyosite/induit chimiquement , Dermatomyosite/diagnostic , Dermatomyosite/immunologie , Mésilate d'imatinib/effets indésirables , Mésilate d'imatinib/usage thérapeutique , Antinéoplasiques/effets indésirables , Antinéoplasiques/usage thérapeutique , Leucémie myéloïde chronique BCR-ABL positive/traitement médicamenteux , Dermatite/étiologie , Dermatite/diagnostic , Dermatite/traitement médicamenteux
9.
Br J Community Nurs ; 29(Sup5): S34-S36, 2024 May 01.
Article de Anglais | MEDLINE | ID: mdl-38728164

RÉSUMÉ

Incontinence-associated dermatitis, previously and sometimes still referred to as moisture lesions or moisture damage, is a commonly seen contact dermatitis that is a reactive response of the skin to chronic contact to urine and faecal matter. Understanding the etiology is fundamental to creating a skin care plan and successfully prevention. Systemic reviews and studies have shown that the continued variability in management results from a combination of knowledge base, observation, diagnosis, and product selection. This article aims to improve clinicians' understanding of incontinence-associated dermatitis and its management.


Sujet(s)
Incontinence anale , Hygiène de la peau , Incontinence urinaire , Humains , Incontinence urinaire/complications , Incontinence anale/complications , Hygiène de la peau/soins infirmiers , Eczéma de contact/étiologie , Femelle , Dermatite/étiologie , Dermatite/soins infirmiers
10.
Front Immunol ; 15: 1369849, 2024.
Article de Anglais | MEDLINE | ID: mdl-38779681

RÉSUMÉ

Background: Stomolophus meleagris envenomation causes severe cutaneous symptoms known as jellyfish dermatitis. The potential molecule mechanisms and treatment efficiency of dermatitis remain elusive because of the complicated venom components. The biological activity and molecular regulation mechanism of Troxerutin (TRX) was firstly examined as a potential treatment for jellyfish dermatitis. Methods: We examined the inhibit effects of the TRX on tentacle extract (TE) obtained from S. meleagris in vivo and in vitro using the mice paw swelling models and corresponding assays for Enzyme-Linked Immunosorbent Assay (ELISA) Analysis, cell counting kit-8 assay, flow cytometry, respectively. The mechanism of TRX on HaCaT cells probed the altered activity of relevant signaling pathways by RNA sequencing and verified by RT-qPCR, Western blot to further confirm protective effects of TRX against the inflammation and oxidative damage caused by TE. Results: TE significantly induced the mice paw skin toxicity and accumulation of inflammatory cytokines and reactive oxygen species in vivo and vitro. Moreover, a robust increase in the phosphorylation of mitogen-activated protein kinase (MAPKs) and nuclear factor-kappa B (NF-κB) signaling pathways was observed. While, the acute cutaneous inflammation and oxidative stress induced by TE were significantly ameliorated by TRX treatment. Notablly, TRX suppressed the phosphorylation of MAPK and NF-κB by initiating the nuclear factor erythroid 2-related factor 2 signaling pathway, which result in decreasing inflammatory cytokine release. Conclusion: TRX inhibits the major signaling pathway responsible for inducing inflammatory and oxidative damage of jellyfish dermatitis, offering a novel therapy in clinical applications.


Sujet(s)
Dermatite , O-(bêta-Hydroxyéthyl)rutosides , Facteur-2 apparenté à NF-E2 , Stress oxydatif , Scyphozoa , Transduction du signal , Animaux , Stress oxydatif/effets des médicaments et des substances chimiques , Souris , Facteur-2 apparenté à NF-E2/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Dermatite/traitement médicamenteux , Dermatite/métabolisme , Dermatite/étiologie , Humains , O-(bêta-Hydroxyéthyl)rutosides/analogues et dérivés , O-(bêta-Hydroxyéthyl)rutosides/pharmacologie , O-(bêta-Hydroxyéthyl)rutosides/usage thérapeutique , Venins de cnidaires/pharmacologie , Heme oxygenase-1/métabolisme , Modèles animaux de maladie humaine , Inflammation/traitement médicamenteux , Inflammation/métabolisme , Mâle , Cytokines/métabolisme , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/usage thérapeutique , Cellules HaCaT , Espèces réactives de l'oxygène/métabolisme , Protéines membranaires
14.
Front Immunol ; 15: 1330011, 2024.
Article de Anglais | MEDLINE | ID: mdl-38495889

RÉSUMÉ

Previously, we reported an anti-inflammatory effect of mTORC1 in a mouse model of type 2 skin inflammation. TSLP, one of the epithelial cell-derived cytokines, was upregulated by Raptor deficiency or rapamycin treatment, which was inhibited by dimethyloxalylglycine (DMOG). However, it remains unclear how DMOG regulates TSLP expression and type 2 skin inflammation. In this study, we investigated the protective effect of DMOG on MC903 (calcipotriol)-induced type 2 skin inflammation. Morphological and immunological changes were assessed by H-E staining, flow cytometry and RT-qPCR. DMOG treatment attenuated MC903-induced skin inflammation in a T cell-independent manner. The anti-inflammatory effect of DMOG was accompanied by downregulation of TSLP and IL-33, and supplementation with recombinant TSLP and IL-33 abolished the effect of DMOG. MC903 increased ROS levels in skin tissue, which was prevented by DMOG. Furthermore, the ROS scavenger N-acetylcysteine (NAC) downregulated TSLP and ameliorated MC903-induced skin inflammation, as did DMOG. Finally, the effect of DMOG on ROS and TSLP was reduced by HIF knockdown. These results suggest that DMOG downregulates TSLP and ROS through the HIF pathway, which reduces MC903-induced skin inflammation.


Sujet(s)
Calcitriol/analogues et dérivés , Dermatite , Prolyl hydroxylases , Animaux , Souris , Interleukine-33 , Espèces réactives de l'oxygène , Dermatite/traitement médicamenteux , Dermatite/étiologie , Dermatite/prévention et contrôle , Anti-inflammatoires , Inflammation
16.
J Wound Ostomy Continence Nurs ; 51(2): 138-145, 2024.
Article de Anglais | MEDLINE | ID: mdl-38527324

RÉSUMÉ

PURPOSE: The purpose of this study was to examine the prevalence of urinary (UI), fecal (FI), and dual incontinence (DI) in older adults and their association with urinary tract infections, dermatitis, slips and falls, and behavioral disturbances based on Medicare fee-for-service (FFS) claims data. DESIGN: Retrospective analysis. SUBJECTS AND SETTINGS: Data from administrative claims from the CMS Medicare Limited Data Set (5% sample) for all months in 2018 were reviewed. The analysis was limited to FFS Medicare beneficiaries, with minimum of 3-month enrollment in Parts A and B who were at least 65 years old. This cohort included 1.2 million beneficiaries in the United States. METHODS: We used diagnosis codes to identify members with incontinence and grouped these members into 3 categories (UI only, FI only, and DI). We also divided claims based on 4 sites of care (nursing home, skilled nursing facility, home health, and self- or family care). We then determined the prevalence of (1) urinary tract infections (UTIs), (2) dermatitis, (3) slips and falls, and (4) behavioral disturbances for each type of incontinence. RESULTS: We found that 11.2% of Medicare members had a claims-based diagnosis of incontinence in 2018. On average, those diagnosed with incontinence experienced 5 times more UTIs, 2 times as many dermatitis events, more than twice as many slips and falls, and 2.8 times more behavior disturbances compared to those without an incontinence diagnosis. For those with DI, the prevalence of the 4 outcomes was significantly higher (between 22% and 185%) compared to those with UI only. CONCLUSIONS: Findings show that Medicare beneficiaries diagnosed as incontinent experience a much higher prevalence of UTIs, dermatitis, slips and falls, and behavioral disturbances compared to those without a diagnosis of incontinence. Our results suggest that incontinence may be an important indicator diagnosis for multiple other conditions and, if not well-managed, may challenge the desire for those who are incontinent to age at home.


Sujet(s)
Dermatite , Incontinence urinaire , Infections urinaires , Humains , Sujet âgé , États-Unis/épidémiologie , Études rétrospectives , Medicare (USA) , Prévalence , Chutes accidentelles , Incontinence urinaire/complications , Incontinence urinaire/épidémiologie , Infections urinaires/complications , Infections urinaires/épidémiologie , Dermatite/épidémiologie , Dermatite/étiologie
17.
Dermatol Clin ; 42(2): 297-305, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38423688

RÉSUMÉ

Neutrophilic dermatosis is a heterogeneous group of inflammatory skin diseases characterized by the presence of a sterile neutrophilic infiltrate on histopathology. Three specific types of neutrophilic dermatoses are reviewed in this article: palisaded neutrophilic granulomatous dermatitis, bowel-associated dermatosis-arthritis syndrome, and rheumatoid neutrophilic dermatitis. The authors review the literature and highlight the clinical and histopathological features, disease pathogenesis, and the association of these conditions with various systemic diseases such as rheumatoid arthritis, inflammatory bowel disease, and others. A multidisciplinary approach is necessary for the diagnosis and management of these inflammatory skin conditions.


Sujet(s)
Polyarthrite rhumatoïde , Dermatite , Maladies inflammatoires intestinales , Maladies de la peau , Humains , Dermatite/étiologie , Dermatite/complications , Polyarthrite rhumatoïde/complications , Polyarthrite rhumatoïde/anatomopathologie , Maladies de la peau/diagnostic , Maladies inflammatoires intestinales/complications , Granulocytes neutrophiles/anatomopathologie
18.
Br Poult Sci ; 65(2): 165-178, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38372652

RÉSUMÉ

1. It was hypothesised that perch material and design may affect utility and maintenance energy demand in laying hens, affecting their feed form preferences and daily feed consumption. Accordingly, perch design and feed form on hen performance, gastrointestinal tract functions and some behavioural and welfare-related traits were studied in laying hens (ATAK-S) reared in enriched colony cages from 24 to 40 weeks of age.2. The experiment was a 2 × 2 factorial investigating two perch materials and design (circular steel or mushroom-shaped plastic) and feed form (mash or crumble). A total of 396 hens were randomly assigned to one of the four treatment groups with nine replicates each (11 birds per replicate).3. Except for feeding behaviour and prevalence of foot pad dermatitis at 40 weeks of age, the modification of the perch design did not have a significant effect on the traits examined. Mushroom-shaped plastic perches reduced feeding behaviour (p < 0.01) and the incidence of foot pad dermatitis at 40 weeks of age (p < 0.001).4. Performance traits were not affected by feed form. Intake, final body weight and FCR for crumble-fed laying hens were greater than those fed mash (p < 0.01).5. Hens fed mash had higher (p < 0.01) relative gizzard weights along with lower (p < 0.05) pH values, pancreatic chymotrypsin, amylase and lipase activities (p < 0.05), and duodenal absorption surface areas (p < 0.01). Ultimately, this gave higher protein digestibility (p < 0.05) compared to those receiving crumble.6. In conclusion, in enriched cage rearing systems, mashed feed was preferred over crumble to efficiently maintain productive performance. Compared to circular steel, plastic mushroom-shaped perches were associated with better footpad health and welfare.


Sujet(s)
Dermatite , Animaux , Femelle , Aliment pour animaux/analyse , Bien-être animal , Poulets , Dermatite/étiologie , Dermatite/médecine vétérinaire , Tube digestif , Hébergement animal , Acier
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...